Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma

被引:25
|
作者
May, James T. [1 ]
Rao, Nikhil [1 ]
Sabater, Roberto D. [1 ]
Boutrid, Hinda [1 ]
Caudell, Jimmy J. [1 ]
Merchant, Faisal [1 ]
Han, Gang [1 ]
Padhya, Tapan A. [1 ]
McCaffrey, Judith C. [1 ]
Tanvetyanon, Tawee [1 ]
Deconti, Ronald [1 ]
Kish, Julie [1 ]
McCaffrey, Thomas V. [1 ]
Trotti, Andy [1 ]
机构
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Head & Neck Oncol Program, Tampa, FL 33612 USA
关键词
intensity-modulated radiation therapy; head and neck cancer; oropharyngeal carcinoma; treatment toxicity; disease control; QUALITY-OF-LIFE; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; DEFINITIVE RADIOTHERAPY; CONCURRENT CHEMOTHERAPY; HEAD; PATTERNS; FAILURE; INFECTION; SURVIVAL;
D O I
10.1002/hed.23245
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundOver the past decade, intensity-modulated radiation therapy (IMRT) has gained widespread use in the treatment of head and neck cancer. MethodsAll patients with squamous cell carcinoma of the oropharynx treated with primary IMRT with or without chemotherapy over a 5-year period were reviewed. Outcomes and morbidity were analyzed and compared with previously published data. ResultsIn all, 170 patients were included in the analysis. The 3-year local control, locoregional control, disease-free survival, and overall survival rates were 92%, 91%, 80%, and 87%, respectively. Feeding tubes were present in 55% of patients during treatment, but remained in only 1% 2 years following treatment. ConclusionsThis study confirms that IMRT yields excellent treatment outcomes for oropharyngeal carcinoma. Although acute toxicity remains a problem, late toxicity rates are low and long-term feeding tube dependence is rare compared with conventional radiation therapy. (c) 2013 Wiley Periodicals, Inc. Head Neck 35: 1796-1800, 2013
引用
收藏
页码:1796 / 1800
页数:5
相关论文
共 50 条
  • [41] Intensity-modulated radiation therapy of anal squamous cell carcinoma: Relationship between delineation quality and regional recurrence
    Rouard, Nathalie
    Peiffert, Didier
    Rio, Emmanuel
    Mahe, Marc-Andre
    Delpon, Gregory
    Marchesi, Vincent
    Falk, Alexander T.
    Salleron, Julia
    Serre, Anne-Agathe
    RADIOTHERAPY AND ONCOLOGY, 2019, 131 : 93 - 100
  • [42] Intensity-modulated radiation therapy
    Lewin, DI
    COMPUTING IN SCIENCE & ENGINEERING, 2002, 4 (05) : 8 - 10
  • [43] Intensity-modulated radiation therapy
    Purdy, JA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (04): : 845 - 846
  • [44] Intensity-modulated radiation therapy
    Anon
    Computing in Science and Engineering, 2002, 4 (05):
  • [45] Intensity-modulated radiation therapy
    不详
    CURRENT PROBLEMS IN CANCER, 2004, 28 (02) : 47 - 84
  • [46] Intensity-modulated radiation therapy
    Carpini, DD
    HEALTH PHYSICS, 2001, 81 (04): : 469 - 469
  • [47] Intensity-modulated radiation therapy
    Lee, N. Y.
    Terezakis, S. A.
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 97 (08) : 691 - 696
  • [48] Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer
    Hunt, MA
    Zelefsky, MJ
    Wolden, S
    Chui, CS
    LoSasso, T
    Rosenzweig, K
    Chong, L
    Spirou, SV
    Fromme, L
    Lumley, M
    Amols, HA
    Ling, CL
    Leibel, SA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (03): : 623 - 632
  • [49] Intensity-modulated radiation therapy for oropharyngeal cancer: Radiation dosage constraint at the anterior mandible
    Verdonck, Henk W. D.
    de Jong, Jos M. A.
    Granzier, Marlies E. P. G.
    Nieman, Fred H.
    de Baat, Cees
    Stoelinga, Paul J. W.
    ORAL ONCOLOGY, 2009, 45 (06) : 511 - 514
  • [50] Clinical Efficacy and Complications of Intensity-modulated Radiation Therapy in Patients With Oropharyngeal Carcinoma: Especially Focus On Osteoradionecrosis
    Keiko Hiramine
    Naonobu Kunitake
    Yuko Shirakawa
    Madoka Abe
    Yoshiyuki Shioyama
    SN Comprehensive Clinical Medicine, 5 (1)